Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Kelliher JC"'
Autor:
Kelliher JC; Integrative and Biomedical Physiology, The Pennsylvania State University, University Park, PA, USA., Maric I; Department of Physiology/Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden., Engeland CG; Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA, USA.; Ross and Carol Nese College of Nursing, The Pennsylvania State University, University Park, PA, USA., Shearer GC; Integrative and Biomedical Physiology, The Pennsylvania State University, University Park, PA, USA.; Nutritional Sciences Department, The Pennsylvania State University, University Park, PA, USA., Skibicka KP; Integrative and Biomedical Physiology, The Pennsylvania State University, University Park, PA, USA.; Department of Physiology/Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Nutritional Sciences Department, The Pennsylvania State University, University Park, PA, USA.
Publikováno v:
American journal of physiology. Regulatory, integrative and comparative physiology [Am J Physiol Regul Integr Comp Physiol] 2024 Dec 24. Date of Electronic Publication: 2024 Dec 24.
Autor:
Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA., Baskin BM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University., Adla Y; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Reed ER; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Jenkins DF; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Cox J; Genetics and Graduate Program in Genetics and Genomics, Program in Biomedical Sciences, Boston University Chobanian & Avedisian School of Medicine., Luong AM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Scotellaro JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Undergraduate Research Opportunity Program (UROP), Boston University., Drescher TA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Crotts SB; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yazdani N; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Ferris MT; Department of Genetics, University of North Carolina, Chapel Hill, NC USA., Johnson WE; Division of Infectious Disease, Department of Medicine, Center for Data Science, Rutgers University, New Jersey, USA., Mulligan MK; Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.
Autor:
Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA.; NIGMS T32 Ph.D. Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts, USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA., Reed ER; Ph.D. Program in Bioinformatics, Boston University, Boston, Massachusetts, USA., Wu Cox J; Program in Biomedical Sciences, Graduate Program in Genetics and Genomics, Boston University School of Medicine, Boston, Massachusetts, USA., Parks C; Department of Agricultural, Biology, and Health Sciences, Cameron University, Lawton, Oklahoma, USA., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA.; NIGMS T32 Ph.D. Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts, USA., Chen MM; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA., Johnson WE; Department of Medicine, Computational Medicine, Boston University School of Medicine, Boston, Massachusetts, USA., Homanics GE; Departments of Anesthesiology, Neurobiology, and Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Williams RW; Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston, Massachusetts, USA., Mulligan MK; Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Publikováno v:
Genes, brain, and behavior [Genes Brain Behav] 2021 Nov; Vol. 20 (8), pp. e12774. Date of Electronic Publication: 2021 Oct 22.
Autor:
Borrelli KN; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Yao EJ; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Yen WW; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Phadke RA; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215.; Molecular Biology, Cell Biology, and Biochemistry (MCBB), Boston University, Boston, Massachusetts 02215., Ruan QT; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Chen MM; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Kelliher JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Langan CR; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Scotellaro JL; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Undergraduate Research Opportunity Program, Boston University, Boston, Massachusetts 02118., Babbs RK; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Beierle JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Logan RW; Laboratory of Sleep, Rhythms, and Addiction, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.; Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, Maine 04609., Johnson WE; Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118., Wachman EM; Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts 02118., Cruz-Martín A; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Bryant CD; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118 camron@bu.edu.
Publikováno v:
ENeuro [eNeuro] 2021 Sep 20; Vol. 8 (5). Date of Electronic Publication: 2021 Sep 20 (Print Publication: 2021).
Autor:
Yao EJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Borrelli KN; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts, USA.; Tranformative Training Program in Addiction Science (TTPAS), Boston University, Boston, Massachusetts, USA.; Biomolecluar Pharmacology Training Program, Boston University School of Medicine, Boston, Massachusetts, USA., Damaj MI; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA., Mulligan MK; Department of Genetics, Genomics, and Informatics, The University of Tennessee Health Science Center, Memphis, Tennessee, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts, USA.; Tranformative Training Program in Addiction Science (TTPAS), Boston University, Boston, Massachusetts, USA.; Biomolecluar Pharmacology Training Program, Boston University School of Medicine, Boston, Massachusetts, USA.
Publikováno v:
Genes, brain, and behavior [Genes Brain Behav] 2021 May 12, pp. e12751. Date of Electronic Publication: 2021 May 12.
Autor:
Awad, Gaëlle1 (AUTHOR), Aubry, Anne-Sophie1 (AUTHOR), Olmstead, Mary C.2 (AUTHOR), Befort, Katia1 (AUTHOR) katia.befort@unistra.fr
Publikováno v:
Nutritional Neuroscience. Nov2024, Vol. 27 Issue 11, p1269-1282. 14p.
Autor:
Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; Biomolecular Pharmacology Ph.D. Program, Boston University School of Medicine, USA; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, 72 E. Concord St., E-200, Boston, MA, 02118, USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Medeiros AR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; National Institute on Drug Abuse Diversity Scholars Program, 6001 Executive Boulevard, Room 3105, MSC 9567, Bethesda, MD, USA, 20892-9567., Anandakumar J; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; National Institute on Drug Abuse Diversity Scholars Program, 6001 Executive Boulevard, Room 3105, MSC 9567, Bethesda, MD, USA, 20892-9567., Shah AA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Chen MM; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Johnson WE; Department of Medicine, Division of Computational Biomedicine, Boston University, 72 E. Concord St., E-609, Boston, MA, 02118, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA. Electronic address: camron@bu.edu.
Publikováno v:
Appetite [Appetite] 2020 Jul 01; Vol. 150, pp. 104678. Date of Electronic Publication: 2020 Mar 21.
Autor:
Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.; T32 NIGMS Training Program in Biomolecular Pharmacology.; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, Boston, MA 02118., Ruan QT; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.; T32 NIGMS Training Program in Biomolecular Pharmacology.; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, Boston, MA 02118., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Chen MM; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Feng AX; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Benitez FA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Rodriguez FA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Pierre JJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Anandakumar J; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Kumar V; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609, and., Mulligan MK; Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, 71 S. Manassas St, Memphis, TN 38163., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry camron@bu.edu.
Publikováno v:
G3 (Bethesda, Md.) [G3 (Bethesda)] 2019 Sep 04; Vol. 9 (9), pp. 3009-3022. Date of Electronic Publication: 2019 Sep 04.
Autor:
Bryant CD; 1 Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; 2 Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Bagdas D; 3 Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.; 4 Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA., Goldberg LR; 1 Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; 2 Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.; 5 Program in Biomolecular Pharmacology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA., Khalefa T; 3 Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.; 4 Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA., Reed ER; 6 Department of Medicine, Computational Biomedicine, Bioinformatics Program, Boston University, Boston, MA, USA., Kirkpatrick SL; 1 Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; 2 Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Kelliher JC; 1 Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; 2 Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Chen MM; 1 Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; 2 Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Johnson WE; 7 Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA., Mulligan MK; 8 Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA., Imad Damaj M; 3 Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.; 4 Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA.
Publikováno v:
Molecular pain [Mol Pain] 2019 Jan-Dec; Vol. 15, pp. 1744806918825046.
Autor:
K.A. Wright, Cummins L, Louis J. Lafrado, Marr Jm, Javadian Ma, Charlene S. Dezzutti, Richard G. Olsen, Kelliher Jc
Publikováno v:
Journal of Medical Primatology. 20:302-307
Chimpanzees were examined for the effect of viral hepatitis infections on specific and nonspecific immune response mechanisms. The data suggest that infection with either hepatitis B virus or hepatitis non-A, non-B virus may result in suppression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88ed6def9d0e264a234bccf9f253c21f
https://doi.org/10.1111/j.1600-0684.1991.tb00540.x
https://doi.org/10.1111/j.1600-0684.1991.tb00540.x